NCT03236129 2023-12-18
DLI-Boost
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
Clinical Trials
88 trialsNCT06073730 2023-10-10
Viale-a
The Second Affiliated Hospital of Kunming Medical University
Phase 3 Unknown
NCT05784870 2023-08-25
A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors
Zhongnan Hospital
Phase 3 Unknown
NCT05020392 2023-07-25
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3 Unknown
NCT04578613 2023-06-05
ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3 Unknown
NCT05264883 2023-05-30
Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Unknown
NCT03846362 2023-03-16
A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 3 Unknown
NCT02172872 2023-02-15
"InDACtion" vs "3+7" Induction in AML
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Unknown
NCT05654194 2022-12-16
Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT05311943 2022-07-29
Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.
Shenzhen Second People's Hospital
Phase 3 Unknown
NCT05457361 2022-07-14
VAH Versus VA for Salvage Therapy of R/R-AML
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT05443854 2022-07-05
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT05382390 2022-05-19
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial
Shengjing Hospital
Phase 3 Unknown
NCT04951323 2022-05-18
Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
University of Liege
Phase 3 Unknown
NCT04375683 2022-03-24
Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL
Zhongda Hospital
Phase 3 Unknown
NCT04490707 2022-03-24
Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML
Zhongda Hospital
Phase 3 Unknown
NCT03942094 2022-03-16
Nilotinib for First-line Newly Diagnosed CML-CP Patients
Shenzhen Second People's Hospital
Phase 3 Unknown
NCT05158608 2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3 Unknown
NCT04722952 2021-12-03
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT04716114 2021-11-02
ALIVE
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 3 Unknown
NCT03257241 2021-10-01
PALG-AML1/2016
Polish Adult Leukemia Group
Phase 3 Unknown
NCT02899169 2021-09-08
APL16
First Affiliated Hospital Xi'an Jiaotong University
Phase 3 Unknown
NCT00651261 2021-08-18
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Phase 3 Unknown
NCT00003337 2021-08-16
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 3 Unknown
NCT04980859 2021-07-28
Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT03800095 2021-03-24
CALVI
University Hospital, Clermont-Ferrand
Phase 3 Unknown
NCT04000698 2020-11-20
Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 3 Unknown
NCT02944045 2020-10-06
PIC
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT02381379 2020-09-14
MSIT
Ministry of Health, Malaysia
Phase 3 Unknown
NCT04446130 2020-06-24
Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT02059720 2020-02-05
Haplo-SCT vs ASCT With or Without Decitabine in AML CR1
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT04087967 2019-09-12
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT04083911 2019-09-10
Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT03978364 2019-06-07
A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC
Shandong Provincial Hospital
Phase 3 Unknown
NCT03655145 2018-08-31
MacHaploMud
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT03515018 2018-05-22
HU
First Affiliated Hospital of Harbin Medical University
Phase 3 Unknown
NCT02991638 2018-04-12
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
The University of Hong Kong
Phase 3 Unknown
NCT01226303 2017-01-26
Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 3 Unknown
NCT02979548 2017-01-25
Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy
All India Institute of Medical Sciences
Phase 3 Unknown
NCT02985372 2016-12-07
Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia
Shandong University
Phase 3 Unknown
NCT02171117 2016-07-13
IMCG-EAML
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 3 Unknown
NCT02757040 2016-04-29
Combination of Ibrutinib and As2O3 in the Treatment of CLL
Peking University People's Hospital
Phase 3 Unknown
NCT02244658 2016-04-20
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Shandong University
Phase 3 Unknown
NCT01067300 2015-10-01
A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission
Assistance Publique Hopitaux De Marseille
Phase 3 Unknown
NCT01423500 2015-06-26
ALL-SCT-BFMi
St. Anna Kinderkrebsforschung
Phase 3 Unknown
NCT01423747 2015-06-26
Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung
Phase 3 Unknown
NCT02070523 2014-07-08
Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia:
Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.
Phase 3 Unknown
NCT00378365 2014-04-16
Acute Promyelocytic Leukemia 2006 (APL)
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT02072785 2014-03-03
LY01609
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT01400074 2014-01-13
RE-NICE
Seoul St. Mary's Hospital
Phase 3 Unknown